Thrombus - 2006


PE and the benefits of LMWH
Marion Delcroix
pp 1-4
The aim of the Belgian Society of Pneumology task force* was to issue guidelines for practitioners, answering simple and practical questions, and emphasising the particularities of pulmonary embolism (PE) compared to venous thromboembolism (VTE). Clinical questions were formulated and evidence was assessed based on previous consensus from the American College of Chest Physicians and the British Thoracic Society, recent systematic reviews (Cochrane Library), computer searches (Medline) and articles.
Comment: Air travel and the risk of thrombosis
Sarah Bond
pp 2-2
Evidence has been slow to emerge to conclusively prove that long haul travel and venous thromboembolism (VTE) are linked. There can be so many variations in each journey and each individual that generalising data is not easy. However, it is now probable that among potential risk factors for triggering thrombosis, sitting for prolonged periods does play an important role as this can cause venous stasis. This factor has been noted as leading to a rise in thrombotic events after trips by car or train as well as by flying.
Haematology nursing at the BSH conference, Edinburgh 2006
Michelle Taylor
pp 5-7
A commitment to providing more time for nursing issues at the British Society of Haematology (BSH) conferences has been steadily gaining momentum over the last few years. At the 46th annual BSH meeting in Edinburgh from 3–5 April 2006, a whole day was dedicated to nursing symposia for the first time, highlighting the continued innovations and research-based findings within haematology presented by specialist nurses. Some excellent presentations were given throughout the day, as well as an opportunity to network with other colleagues to discuss best practice.
A case of DVT in a 13-year-old girl with osteochondroma
Sarah Bond
pp 8-8
A 13-year-old girl presented to hospital via her GP with a three-day history of left leg pain from mid-thigh to calf and a difficulty in weight bearing. She had pulled a muscle in dance class six weeks earlier, which had resulted in a painful leg, but this had resolved without treatment. She was not taking the oral contraceptive pill and had no family history of venous thromboembolism (VTE). She was diagnosed with osteochondroma at the age of seven when an X-ray was performed on multiple lumps on her legs. She was under ongoing review by the orthopaedic team but as the lesions did not cause her pain unless directly knocked and were not growing
Self-management of oral anticoagulation: the SMART study
David Fitzmaurice
pp 9-11
The expansion of clinical indications for oral anticoagulation therapy (primarily warfarin in the UK), particularly nonrheumatic atrial fibrillation, has raised concerns over how therapeutic monitoring should be undertaken. The significance of this issue for all healthcare systems with aging populations can be estimated from data showing that of patients with identified atrial fibrillation, only one-third are currently receiving anticoagulation. Furthermore, in the absence of screening programmes, a high proportion of patients with atrial fibrillation remain unidentified.

Thrombus was previously supported by Bayer from 2014 to 2016, by Boehringer Ingelheim from 2009 to 2013, by sanofi-aventis from 2007 to 2008 and by Leo Pharma from 1998 to 2006.

The data, opinions and statements appearing in the articles herein are those of the contributor(s) concerned; they are not necessarily endorsed by the sponsor, publisher, Editor or Editorial Board. Accordingly the sponsor, publisher, Editor and Editorial Board and their respective employees, officers and agents accept no liability for the consequences of any such inaccurate or misleading data, opinion or statement.

The title Thrombus is the property of Hayward Medical Publishing and PMGroup Worldwide Ltd and, together with the content, is bound by copyright. Copyright © 2019 PMGroup Worldwide Ltd. All rights reserved. The information contained on the site may not be reproduced, distributed or published, in whole or in part, in any form without the permission of the publishers. All correspondence should be addressed to: admin@hayward.co.uk

ISSN 1369-8117 (Print)  ISSN 2045-7855 (Online)

Site Map | company profile | contact us | testimonials | current vacancies | © 2011 - 2024 Your Company Name